---

Clinical Synthesis: Severe Hypothyroidism with Multi-Organ Involvement

---

Unifying Diagnosis: Myxedema Crisis

---

Feature-by-Feature Breakdown

1. Acute Delirium / Altered Consciousness

• Hypothermia (core temp 87–91°F / 30.5–32.7°C) — the most dramatic sign
• Hypoventilation with CO₂ retention and mild hypoxia
• EEG: diffuse background slowing, triphasic waves
• Pseudo-myotonic stretch reflexes — normal jerk but markedly slow relaxation phase (pathognomonic)
• Decreased cerebral blood flow and glucose metabolism
• Hyponatremia (from SIADH) — can be severe enough to cause seizures, and itself worsens consciousness
• Elevated serum muscle enzymes (CK)

"In a series of 11 patients either stuporous or comatose from hypothyroidism, three of four patients who were in a coma on admission died, whereas only one of seven patients with less severe changes of consciousness died." — Plum and Posner

2. Imbalance / Gait Ataxia

• Proximal myopathy (most common PNS complication) with myalgia and muscle stiffness
• Sensorimotor peripheral neuropathy (segmental demyelination + axonal degeneration)
• Hypothermia impairing proprioception and coordination
• Encephalopathy lowering postural control

3. Right Upper Lobe Consolidation (Pneumonia)

"The onset of myxedema coma is usually acute or subacute and precipitated by stressors such as infection, congestive heart failure, trauma, exposure to cold, or sedative/anesthetic drug administration in an untreated hypothyroid patient." — Plum and Posner

• Streptococcus pneumoniae (lobar pneumonia, any lobe)
• Klebsiella pneumoniae (classic upper lobe predilection, "bulging fissure" sign)
• Staphylococcus aureus (post-influenza, cavitating)
• TB reactivation (upper lobe — always consider, especially in immunocompromised/hypothyroid state)
• Aspiration (if obtunded before presentation)

4. AKI with Glomerulonephritis

• Decreased cardiac output → reduced renal perfusion → pre-renal AKI
• Hypothyroidism reduces GFR directly (thyroid hormone has intrinsic renal vasodilatory effects)
• Hyponatremia and volume redistribution

---

Priority Investigations

---

Emergency Management

Step 1 — Immediate (ICU)

"Treatment with intravenous glucocorticoids is recommended until coexisting adrenal insufficiency is excluded." — Goodman & Gilman's

Step 2 — Ongoing

• Serial TSH/free T4 monitoring
• Nephrology referral for AKI-GN management (avoid nephrotoxic antibiotics, contrast)
• Renal biopsy once hemodynamically stable
• If Hashimoto's encephalopathy suspected (serum anti-TPO strongly positive, CSF inflammatory): consider IV methylprednisolone

---

Prognosis

• Mortality 25–50% even with treatment (higher if coma vs. pre-coma)
• Better prognosis with early recognition, aggressive thyroid hormone replacement, and treatment of precipitant
• Neurological complications typically resolve with thyroid replacement if not long-standing
• GN prognosis depends on subtype — membranous GN associated with hypothyroidism often improves with thyroid treatment alone

---

Key References

• Plum and Posner's Diagnosis and Treatment of Stupor and Coma — Myxedema section
• Bradley and Daroff's Neurology in Clinical Practice — Hypothyroidism neurological complications
• Goodman & Gilman's The Pharmacological Basis of Therapeutics — Myxedema Coma treatment
• Cummings Otolaryngology — Myxedema Coma as thyroid emergency

---

Updated Clinical Synthesis: Fever-Precipitated Myxedema Crisis vs. Competing Diagnoses

---

The Critical Diagnostic Tension: Fever + Severe Hypothyroidism

Fever is NOT typical of myxedema crisis

Is this myxedema crisis triggered by a febrile illness — or is the primary process the infection itself driving multi-organ dysfunction, with severe hypothyroidism as a co-morbid amplifier?

---

Diagnostic Framework: Two Simultaneous Critical Processes

Severe Hypothyroidism (baseline)
        ↓
RUL Pneumonia (precipitant / primary infection)
        ↓
  ┌─────────────────────────────────────┐
  │  FEVER          (infection)         │
  │  Delirium       (multi-factorial)   │
  │  Imbalance      (hypothyroid + sepsis)│
  │  Hyponatremia   (SIADH + hypothyroid)│
  │  AKI + GN       (immune/septic)     │
  └─────────────────────────────────────┘

---

Feature-by-Feature Analysis (Updated with Fever)

1. Fever

---

2. Acute Delirium — Now Multi-factorial

---

3. Imbalance

• Cerebellar degeneration from hypothyroidism (truncal ataxia)
• Peripheral neuropathy (sensorimotor, demyelinating)
• Proximal myopathy from hypothyroidism
• Septic/toxic encephalopathy impairing vestibulo-cerebellar coordination
• Hyponatremia further impairing proprioception and postural reflexes

---

4. Mild Hyponatremia — Key Mechanistic Insight

"Hypothyroidism and adrenal glucocorticoid insufficiency can be associated with hypotonic hyponatremia that mimics SIADH without clinically evident hypovolemia." — Goldman-Cecil Medicine

"A radiograph or chest CT scan may help identify intrathoracic lesions that are associated with SIADH." — Goldman-Cecil Medicine

---

5. AKI with Glomerulonephritis — Revised Differential

---

Revised Investigation Priority

Urgent (same day, before treatment delay):

GN Workup (urgent, within 24h):

Imaging:

---

Emergency Management (Revised for Febrile Patient)

ICU-Level Care Required

• If Na⁺ ≥125 and asymptomatic-mild: fluid restriction (800–1000 mL/day)
• If Na⁺ <125 or contributing to seizures/severe delirium: 3% hypertonic saline 100 mL IV over 10 min, repeat × 1–2 if seizing; target correction ≤8–10 mEq/L per 24h (avoid osmotic demyelination)
• Treating the underlying hypothyroidism + infection resolves the SIADH — this is the definitive treatment

• Avoid nephrotoxic antibiotics (aminoglycosides, vancomycin without monitoring)
• Avoid iodinated contrast until AKI resolves
• If ANCA or anti-GBM positive: urgent immunosuppression (pulse methylprednisolone ± cyclophosphamide/rituximab) — discuss with nephrology before initiating given active infection
• Renal biopsy as soon as clinically feasible (coagulopathy from hypothyroidism must be corrected first)

---

Diagnostic Hierarchy Summary

MOST URGENT TO EXCLUDE:
1. ANCA vasculitis (pulmonary-renal syndrome) → ANCA now
2. Anti-GBM disease (Goodpasture) → anti-GBM now
3. TB (RUL, immunocompromised) → AFB smear/cultures now
4. Adrenal insufficiency → cortisol before T4
5. Sepsis bacteraemia → blood cultures before antibiotics

WORKING DIAGNOSIS:
• Myxedema crisis precipitated by community-acquired pneumonia (RUL)
• Multi-factorial delirium (hypothyroid + septic + hyponatraemic + hypoxic)
• AKI: likely pre-renal + possible immune-complex GN (post-infectious vs Hashimoto-associated membranous)
• Mild hyponatremia: SIADH from hypothyroidism + pneumonia
• Imbalance: cerebellar/peripheral hypothyroid neuropathy + toxic-metabolic encephalopathy

---

Prognosis

• Mortality: 25–50% for myxedema crisis; worsened by concurrent sepsis
• Prompt thyroid hormone replacement + antibiotics + hydrocortisone cover are the key modifiable factors
• GN prognosis depends on subtype — if post-infectious: typically self-limiting; if vasculitis: requires urgent immunosuppression despite active infection (high-stakes clinical decision)
• Hyponatremia and renal function typically improve with treatment of the underlying hypothyroidism and infection

---

---

Empirical Treatment of Bacterial Meningitis

Time target: antibiotics within 60 minutes of ED arrival. Do not delay antibiotics for LP if CT or LP will take >30 min. — Harrison's Principles of Internal Medicine, 22e (2025)

---

Step 1 — Adjunctive Dexamethasone (Give FIRST or With First Antibiotic Dose)

• Reduces neurologic sequelae (especially hearing loss) in H. influenzae meningitis in children
• Reduces mortality and morbidity in adults with pneumococcal meningitis
• Discontinue if cultures reveal a non-pneumococcal, non-H. influenzae organism
• Caveat: Dexamethasone reduces CNS inflammation and may reduce vancomycin penetration into the CSF — if pneumococcal meningitis is confirmed, ensure adequate vancomycin dosing/monitoring

---

Step 2 — Empirical Antibiotic Regimen (by Age/Risk)

🔵 Preterm infants and neonates <1 month

🔵 Infants 1–3 months

🟢 Immunocompetent children >3 months and adults ≤55 years

🟡 Adults >55 years OR alcoholism / debilitating illness

🔴 Hospital-acquired / Post-neurosurgery / Post-traumatic / Neutropenic / Impaired cell-mediated immunity

---

Neonatal Dosing Reference

---

Additional Empirical Additions (Situational)

---

Pathogen-Directed Therapy (once cultures/sensitivities available)

---

Key Principles

1. Speed over perfection — antibiotics within 60 min, regardless of LP status
2. Dexamethasone before or with first antibiotic dose — not after
3. Vancomycin is mandatory in all empirical regimens (except neonates/infants <1 month) due to penicillin/cephalosporin-resistant S. pneumoniae
4. Add ampicillin for anyone >55, immunocompromised, pregnant, or with debilitating illness → Listeria coverage
5. Add acyclovir until HSV encephalitis excluded (clinically indistinguishable at presentation)
6. De-escalate based on culture/sensitivity results — do not continue broad empirical therapy beyond 48–72h if pathogen identified

---

Prognosis

---

Naloxone Dosing

---

Opioid Overdose / Respiratory Depression (Emergency)

• Goal: Restore adequate spontaneous ventilation — not full awakening (over-reversal causes agitation, pain, and sympathetic crisis)
• Maximum before reconsidering diagnosis: If no response after 10 mg total, question whether opioids are the primary cause
• Observation period: At least 60–90 minutes after the last dose if ≤1 mg total given IV

---

Continuous Infusion (Long-acting opioids — methadone, extended-release, buprenorphine)

---

Peri-operative / Post-anesthesia Setting (partial reversal preferred)

• Careful titration preserves residual analgesia while reversing respiratory depression
• Avoid full reversal — causes pain recurrence, hypertension, tachycardia, rarely pulmonary oedema

---

Paediatric Dosing

---

Special Situations

---

Key Pharmacokinetics

The short duration relative to most opioids means re-narcotization is the rule, not the exception with long-acting opioids. Always monitor and have a re-dosing or infusion plan ready.